文献速递消化道肿瘤与早癌

结直肠癌分子分型与患者生存的关联:一项系统综述

Associations Between Molecular Classifications of Colorectal Cancer and Patient Survival: A Systematic Review.
PubMed 文献 · Clin Gastroenterol Hepatol · 2018-01-03

该系统综述检索多个数据库,纳入使用至少3种分子标志物对肿瘤分型并提供各亚型生存估计的研究,共纳入6项研究。多数分型系统提出5种亚型,包含微卫星不稳定、BRAF和KRAS突变信息,但均未整合TNM分期;仅3项研究提供内部或外部验证。结论为多数亚型与生存无显著或差异性关联,需进一步研究与验证。

要点

  • 共纳入6项研究,多数分型系统提出5种亚型,包含微卫星不稳定、BRAF和KRAS突变信息。
  • 无一项分型系统整合TNM分期,仅3项研究提供内部或外部验证。
  • 微卫星稳定且伴KRAS或BRAF突变的肿瘤,与微卫星稳定且无突变者相比,生存时间缩短。

核心结论

  • 多数分子亚型与生存无显著关联或无差异性关联,无分型系统整合TNM分期,需进一步研究与验证以开发适用于临床实践的分子亚型分类系统。

研究设计与样本

  • 系统综述,检索PubMed、Embase、Cochrane和Web of Science数据库,仅纳入使用至少3种分子标志物对肿瘤分型并提供各亚型生存估计的研究,由2名评价员独立提取数据并评估质量,最终纳入6项研究。

主要发现

  • 共纳入6项研究,分子亚型基于肿瘤发生相关通路或基因表达聚类分析结果进行划分。
  • 多数研究提出包含5种亚型的分类系统,涵盖微卫星不稳定、BRAF突变和KRAS突变信息。
  • 无一项研究将TNM分期纳入分类系统,3种分类系统使用了相似的定义。
  • 仅3项研究对提出的分类方案提供了内部或外部验证。
  • 微卫星稳定且伴KRAS或BRAF突变的肿瘤,与微卫星稳定且无突变者相比,生存时间缩短。

关键数值与推荐

  • 纳入标准为使用至少3种分子标志物对肿瘤分型并提供各亚型生存估计的研究。
  • 多数分型系统包含5种亚型,涉及微卫星不稳定、BRAF突变和KRAS突变信息。
  • 3种分类系统使用了相似的定义,仅3项研究提供内部或外部验证。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 仅3项研究对提出的分类方案提供了内部或外部验证。
  • 无一项研究将TNM分期纳入分类系统。
  • 需进一步研究和验证以开发适用于临床实践的分子亚型分类系统。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: Colorectal cancer (CRC) is a heterogeneous disease with different mechanisms of pathogenesis. Classification systems have been proposed based on molecular features of tumors, but none are used in clinical practice. We performed a systematic review of studies on the associations between molecular classifications of CRC and patient survival. METHODS: We searched the PubMed, Embase, Cochrane, and Web of Science databases for combinations of terms related to CRC, molecular markers, subtype classifications, and survival (overall survival, disease-specific survival, disease-free survival). We included only studies that used at least 3 molecular markers to classify tumors and provided an estimate of survival associated with each subtype. Data extraction and quality assessment were performed independently by 2 reviewers. RESULTS: We identified 6 studies that fulfilled the inclusion criteria. In these studies, molecular subtypes were assigned based on pathways associated with tumor development or findings from gene expression clustering analyses. Most studies proposed classification systems with 5 subtypes, including information on microsatellite instability, mutations in BRAF, and mutations in KRAS. None of the studies included TNM stage in their classification system. Three classification systems used similar definitions. Only 3 studies provided internal or external validation of the proposed classification schemes. Tumors with microsatellite stability and mutations in KRAS or BRAF were associated with decreased survival times, compared with tumors with microsatellite stability and no mutations. CONCLUSIONS: In a systematic review of studies of molecular classifications of CRC and patient survival, we found that most subtypes were not significantly or not differentially associated with survival. None of the systems integrated TNM staging. Further research and validation are needed to develop molecular subtype classification systems for clinical practice.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Alwers E, Jia M, Kloor M, et al. Associations Between Molecular Classifications of Colorectal Cancer and Patient Survival: A Systematic Review. Clin Gastroenterol Hepatol. 2018. PMID: 29306042. doi:10.1016/j.cgh.2017.12.038

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。